Effects of magnolol and honokiol on adhesion, yeast-hyphal transition, and formation of biofilm by candida albicans

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Sun, Lingmei ^a   Liao, Kai ^a   Wang, Dayong ^a  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CYCLIC AMP; HONOKIOL; MAGNOLOL; ANTIFUNGAL AGENT; BIPHENYL DERIVATIVE; FUNGAL PROTEIN; HERBACEOUS AGENT; LIGNAN; TITANIUM;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFUNGAL ACTIVITY; ARTICLE; BIOFILM; CAENORHABDITIS ELEGANS; CAMP GENE; CANDIDA ALBICANS; CANDIDIASIS; CELL ADHESION; CONCENTRATION RESPONSE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG MECHANISM; DRUG SAFETY; DRUG STRUCTURE; EFG1 GENE; FUNGAL GENE; FUNGAL VIABILITY; FUNGUS GROWTH; FUNGUS HYPHAE; MAMMAL CELL; MEMBRANE FORMATION; NONHUMAN; RAS1 GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; YOUNG ADULT; ANIMAL; CELL LINE; CHEMISTRY; CONFOCAL MICROSCOPY; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; RAT; SIGNAL TRANSDUCTION; VIRULENCE;

CAENORHABDITIS ELEGANS; CANDIDA ALBICANS; MAMMALIA; NEMATODA;

ANIMALS; ANTIFUNGAL AGENTS; BIOFILMS; BIPHENYL COMPOUNDS; CAENORHABDITIS ELEGANS; CANDIDA ALBICANS; CELL ADHESION; CELL LINE; DRUGS, CHINESE HERBAL; FUNGAL PROTEINS; HYPHAE; LIGNANS; MICROSCOPY, CONFOCAL; MODELS, ANIMAL; RATS; SIGNAL TRANSDUCTION; TITANIUM; VIRULENCE;

EID: 84923353635     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0117695     Document Type: Article

References (38)

1. Miller LG, Hajjeh RA, Edwards JJ (2001) Estimating the cost of nosocomial candidemia in the united states. Clin Infect Dis 32: 1110. PMID: 11264044
2. Pappas PG, Rex JH, Lee J, Hamill RJ, Larsen RA, et al. (2003) A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin Infect Dis 37: 634-643. PMID: 12942393
3. Dos SAP, McArthur CP, Africa CW (2014) Multi-drug resistant oral Candida species isolated from HIV-positive patients in South Africa and Cameroon. Diagn Microbiol Infect Dis 79: 222-227. doi: 10.1016/j.diagmicrobio.2013.09.016 PMID: 24726686
4. Ruhnke M (2014) Antifungal stewardship in invasive Candida infections. Clin Microbiol Infect 20 Suppl 6: 11-18. doi: 10.1111/1469-0691.12622 PMID: 24661820
5. Alexander BD, Perfect JR (1997) Antifungal resistance trends towards the year 2000. Implications for therapy and new approaches. Drugs 54: 657-678. PMID: 9360056
6. Ferreira AV, Prado CG, Carvalho RR, Dias KS, Dias AL (2013) Candida albicans and non-C. albicans Candida species: comparison of biofilm production and metabolic activity in biofilms, and putative virulence properties of isolates from hospital environments and infections. Mycopathologia 175: 265-272. doi: 10.1007/s11046-013-9638-z PMID: 23532754
7. Biswas S, Van Dijck P, Datta A (2007) Environmental sensing and signal transduction pathways regulating morphopathogenic determinants of Candida albicans. Microbiol Mol Biol Rev 71: 348-376. PMID: 17554048
8. Blankenship JR, Mitchell AP (2006) How to build a biofilm: a fungal perspective. Curr Opin Microbiol 9: 588-594. PMID: 17055772
9. Finkel JS, Mitchell AP (2011) Genetic control of Candida albicans biofilm development. Nat Rev Microbiol 9: 109-118. doi: 10.1038/nrmicro2475 PMID: 21189476
10. Lopez-Ribot JL (2005) Candida albicans biofilms: more than filamentation. Curr Biol 15: R453-R455. PMID: 15964263
11. Inigo M, Peman J, Del PJ (2012) Antifungal activity against Candida biofilms. Int J Artif Organs 35: 780-791. doi: 10.5301/ijao.5000170 PMID: 23138707
12. Harvey A (2010) The role of natural products in drug discovery and development in the new millennium. IDrugs 13: 70-72. PMID: 20127553
13. Bauer A, Bronstrup M (2014) Industrial natural product chemistry for drug discovery and development. Nat Prod Rep 31: 35-60. doi: 10.1039/c3np70058e PMID: 24142193
14. Cragg GM, Newman DJ, Snader KM (1997) Natural products in drug discovery and development. J Nat Prod 60: 52-60. PMID: 9014353
15. Newman DJ, Cragg GM, Snader KM (2003) Natural products as sources of new drugs over the period 1981-2002. J Nat Prod 66: 1022-1037. PMID: 12880330
16. Bang KH, Kim YK, Min BS, Na MK, Rhee YH, et al. (2000) Antifungal activity of magnolol and honokiol. Arch Pharm Res 23: 46-49. PMID: 10728656
17. Jacobo-Salcedo MR, Gonzalez-Espindola LA, Alonso-Castro AJ, Gonzalez-Martinez MR, Dominguez F, et al. (2011) Antimicrobial activity and cytotoxic effects of Magnolia dealbata and its active compounds. Nat Prod Commun 6: 1121-1124. PMID: 21922914
18. Jin J, Guo N, Zhang J, Ding Y, Tang X, et al. (2010) The synergy of honokiol and fluconazole against clinical isolates of azole-resistant Candida albicans. Lett Appl Microbiol 51: 351-357. doi: 10.1111/j.1472-765X.2010.02900.x PMID: 20681969
19. Fonzi WA, Irwin MY (1993) Isogenic strain construction and gene mapping in Candida albicans. Genetics 134: 717-728. PMID: 8349105
20. Sun L, Sun S, Cheng A, Wu X, Zhang Y, et al. (2009) In vitro activities of retigeric acid B alone and in combination with azole antifungal agents against Candida albicans. Antimicrob Agents Chemother 53: 1586-1591. doi: 10.1128/AAC.00940-08 PMID: 19171796
21. Larsen B, Anderson S, Brockman A, Essmann M, Schmidt M (2006) Key physiological differences in Candida albicans CDR1 induction by steroid hormones and antifungal drugs. Yeast 23: 795-802. PMID: 16921553
22. Chang W, Li Y, Zhang L, Cheng A, Lou H (2012) Retigeric acid B attenuates the virulence of Candida albicans via inhibiting adenylyl cyclase activity targeted by enhanced farnesol production. PLoS One 7: e41624. doi: 10.1371/journal.pone.0041624 PMID: 22848547
23. rd ed., 2008. Wayne, PA
24. Wu XZ, Cheng AX, Sun LM, Sun SJ, Lou HX (2009) Plagiochin E, an antifungal bis(bibenzyl), exerts its antifungal activity through mitochondrial dysfunction-induced reactive oxygen species accumulation in Candida albicans. Biochim Biophys Acta 1790: 770-777. doi: 10.1016/j.bbagen.2009.05.002 PMID: 19446008
25. Tobudic S, Forstner C, Schranz H, Poeppl W, Vychytil A, et al. (2013) Comparative in vitro fungicidal activity of echinocandins against Candida albicans in peritoneal dialysis fluids. Mycoses 56: 623-630. doi: 10.1111/myc.12079 PMID: 23551835
26. Toenjes KA, Munsee SM, Ibrahim AS, Jeffrey R, Edwards JJ, et al. (2005) Small-molecule inhibitors of the budded-to-hyphal-form transition in the pathogenic yeast Candida albicans. Antimicrob Agents Chemother 49: 963-972. PMID: 15728890
27. de Freitas MM, Da SC, Groisman M, Vidigal GJ (2011) Comparative analysis of microorganism species succession on three implant surfaces with different roughness: an in vivo study. Implant Dent 20: e14-e23. doi: 10.1097/ID.0b013e31820fb99e PMID: 21448015
28. Ahariz M, Courtois P (2010) Candida albicans biofilm on titanium: effect of peroxidase precoating. Med Devices (Auckl) 3: 33-40. PMID: 22915919
29. Chen G, Wang Y, Li M, Xu T, Wang X, et al. (2014) Curcumol induces HSC-T6 cell death through suppression of Bcl-2: Involvement of PI3K and NF-κB pathways. Eur J Pharm Sci 65C: 21-28.
30. Sun LM, Cheng AX, Wu XZ, Zhang HJ, Lou HX (2010) Synergistic mechanisms of retigeric acid B and azoles against Candida albicans. J Appl Microbiol 108: 341-348. doi: 10.1111/j.1365-2672.2009.04429.x PMID: 20002912
31. Fazly A, Jain C, Dehner AC, Issi L, Lilly EA, et al. (2013) Chemical screening identifies filastatin, a small molecule inhibitor of Candida albicans adhesion, morphogenesis, and pathogenesis. Proc Natl Acad Sci U S A 110: 13594-13599. doi: 10.1073/pnas.1305982110 PMID: 23904484
32. Breger J, Fuchs BB, Aperis G, Moy TI, Ausubel FM, et al. (2007) Antifungal chemical compounds identified using a C. elegans pathogenicity assay. PLoS Pathog 3: e18. PMID: 17274686
33. Perumal P, Mekala S, Chaffin WL (2007) Role for cell density in antifungal drug resistance in Candida albicans biofilms. Antimicrob Agents Chemother 51: 2454-2463. PMID: 17502416
34. Staab JF, Bradway SD, Fidel PL, Sundstrom P (1999) Adhesive and mammalian transglutaminase substrate properties of Candida albicans Hwp1. Science 283: 1535-1538. PMID: 10066176
35. Nobile CJ, Nett JE, Andes DR, Mitchell AP (2006) Function of Candida albicans adhesin Hwp1 in biofilm formation. Eukaryot Cell 5: 1604-1610. PMID: 17030992
36. Feldman M, Al-Quntar A, Polacheck I, Friedman M, Steinberg D (2014) Therapeutic potential of thiazoli-dinedione-8 as an antibiofilm agent against Candida albicans. PLoS One 9: e93225. doi: 10.1371/journal.pone.0093225 PMID: 24796422
37. Nobile CJ, Andes DR, Nett JE, Smith FJ, Yue F, et al. (2006) Critical role of Bcr1-dependent adhesins in C. albicans biofilm formation in vitro and in vivo. PLoS Pathog 2: e63. PMID: 16839200
38. Hogan DA, Sundstrom P (2009) The Ras/cAMP/PKA signaling pathway and virulence in Candida albicans. Future Microbiol 4: 1263-1270. doi: 10.2217/fmb.09.106 PMID: 19995187